Dopamine D3 receptor agents as potential new medications for drug addiction

European Psychiatry

Volumn 15, Issue 2, 2000, Pages 140-146

  Le Foll, B ^a   Schwartz, J C ^a   Sokoloff, P ^a  

^a CENTRE PAUL BROCA   (France)

Author keywords

Behavioral sensitisation; Cocaine; Drug associated cues; Nucleus accumbens shell; Synergism

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; APOMORPHINE; BP 897; BROMOCRIPTINE; COCAINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; LEVODOPA; LISURIDE; MESSENGER RNA; PRAMIPEXOLE; QUINELORANE; QUINPIROLE; SUBSTANCE P; UNCLASSIFIED DRUG; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; NAFADOTRIDE; NAPHTHALENE DERIVATIVE; PYRROLIDINE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG ABUSE; DRUG TARGETING; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SENSITIZATION; ANIMAL; DISEASE MODEL; DRUG EFFECT; DRUG POTENTIATION; LOCOMOTION; METABOLISM; NERVE CELL; REWARD;

ANIMALS; COCAINE; COCAINE-RELATED DISORDERS; DISEASE MODELS, ANIMAL; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DRUG SYNERGISM; LOCOMOTION; NAPHTHALENES; NEURONS; NUCLEUS ACCUMBENS; PYRROLIDINES; RATS; RECEPTORS, DOPAMINE; REWARD;

EID: 0033624074     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(00)00219-4     Document Type: Article

References (49)

1. Altman J., Everitt B.J., Glautier S., Markou A., Nutt D., Oretti R., et al. The biological, social and clinical bases of drug addiction: commentary and debate. Psychopharmacology (Berl). 125:1996;285-345.
2. Arroyo M., Markou A., Robbins T.W., Everitt B.J. Acquisition, maintenance and reinstatement of intravenous cocaine self-administration under a second-order schedule of reinforcement in rats : effects of conditioned cues and continuous access to cocaine. Psychopharmacology. 140:1999;331-344.
3. Bordet R., Ridray S., Carboni S., Diaz J., Sokoloff P., Schwartz J.C. Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa. Proc Natl Acad Sci USA. 94:1997;3363-3367.
4. Bouthenet M.L., Souil E., Martres M.P., Sokoloff P., Giros B., Schwartz J.C. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with D2 receptor mRNA. Brain Res. 564:1991;203-219.
5. Cabib S., Castellano C., Cestari V., Filibeck U., Puglisi-Allegra S. D1 and D2 receptor antagonists differently affect cocaine-induced locomotor hyperactivity in the mouse. Psychopharmacology (Berl). 105:1991;335-339.
6. Caine S.B., Koob G.F. Modulation of cocaine self-administration in the rat through D3 dopamine receptors. Science. 260:1993;1814-1816.
7. Caine S.B., Koob G.F. Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther. 270:1994;209-218.
8. Caine S.B., Koob G.F. Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat. Behav Pharmacol. 6:1995;333-347.
9. Caine S.B., Koob G.F., Parsons L.H., Everitt B.J., Schwartz J.C., Sokoloff P. D3 receptor test in vitro predicts decreased cocaine self-administration in rats. Neuroreport. 8:1997;2373-2377.
10. Childress E.R., Roohsenow D.J., Robbins S.H., O'Brien C.P. Classically conditioned factors in drug dependence. Lowinson W, Luiz P, Millman R.B, Langard J.G. Substance abuse: a comprehensive text book. 1992;56-69 Baltimore: Williams and Wilkins.
11. Cole R.L., Konradi C., Douglass J., Hyman S.E. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron. 14:1995;813-823.
12. DeWit H., Stewart J. Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacol. 75:1981;134-143.
13. DiChiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA. 85:1988;5274-5278.
14. Diaz J., Lévesque D., Lammers C.H., Griffon N., Martres M.P., Schwartz J.C., et al. Phenotypical characterization of neurons expressing the dopamine D3 receptor. Neuroscience. 65:1995;731-745.
15. Duaux E., Gorwood P., Sautel F., Griffon N., Sokoloff P., Schwartz J.C., et al. Homozygosity at the dopamine D3 receptor gene is associated with opioid dependence. Mol Psychiatry. 3:1998;333-336.
16. Gawin F.W. Cocaine addiction: psychology and neurophysiology. Science. 251:1991;1580-1586.
17. Grech D.M., Spealman R.D., Bergman J. Self-administration of D1 receptor agonists by squirrel monkeys. Psychopharmacol. 125:1996;97-104.
18. Griffon N., Pilon C., Sautel F., Schwartz J.C., Sokoloff P. Two intracellular pathways for the dopamine D3 receptor: opposite and synergistic interactions with cyclic AMP. J Neurochem. 67:1997;1-9.
19. Heimer L., Zham D.S., Alheid G.F. Basal ganglia. Paxinos G. The rat nervous system. 1995;579-628 New York: Academic Press.
20. Horger B.A., Shelton K., Schenk S. Preexposure sensitizes rats to the rewarding effects of cocaine. Pharmacol Biochem Behav. 37:1990;707-711.
21. Kalivas P.W., Stewart J. Dopamine transmission in the initition and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev. 16:1991;223-244.
22. Koob G.F. Dopamine, addiction and reward. Sem Neurosci. 4:1992;139-148.
23. Krebs M.O., Sautel F., Bourdel M.C., Sokoloff P., Schwartz J.C., Olié J.P., et al. Dopamine D3 receptor gene variants and substance abuse in schizophrenia. Mol Psychiatry. 3:1998;337-341.
24. Lamas X., Negus S.S., Nader M.A., Mello N.K. Effects of putative dopamine D3 receptor agonist 7-OH-DPAT in rhesus monkeys trained to discriminate cocaine from saline. Psychopharmacology (Berl). 124:1996;306-314.
25. Lett B.T. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacol. 98:1989;357-362.
26. Lévesque D., Diaz J., Pilon C., Martres M.P., Giros B., Souil E., et al. Identification, characterization and localization of the dopamine D3 receptor in rat brain using 7. -[3H]-hydroxy-N, N di-n-propyl-2-aminotetralin. Proc Natl Acad Sci USA. 89:1992;8155-8159.
27. Lévesque D., Martres M.P., Diaz J., Griffon N., Lammers C.H., Sokoloff P., et al. A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons. Proc Natl Acad Sci USA. 92:1995;1719-1723.
28. Maldonado R., Robledo P., Chover A.J., Caine S.B., Koob G.F. D1 dopamine receptors in the nucleus accumbens modulate cocaine self-administration in the rat. Pharmacol Biochem Behav. 45:1993;239-242.
29. Meil W.M., See R.E. Conditioned cue recovery of responding following prolonged withdrawal from self-administered cocaine in rats: an animal model of relapse. Behav Pharmacol. 7:1996;754-763.
30. Meil W.M., See R.E. Lesions of the basolateral amygdala abolish the ability of drug-associated cues to reinstate responding during withdrawal from self-administered cocaine. Behav Brain Res. 87:1997;139-148.
31. Milner P.M. Brain-stimulation reward: a review. Can J Psychol. 45:1991;1-36.
32. Nestler E.J. Molecular mechanisms of drug addiction. J Neurosci. 12:1992;2439-2450.
33. O'Brien C.P., Childress A.R., McMellan A.T., Ehrman R.A. A learning model of addiction. Res Publ Assoc Res Nerv Ment Dis. 70:1992;157-177.
34. O'Brien C.P., McMellan A.T. Myths about the treatment of addiction. Lancet. 347:1996;237-240.
35. Pennartz C.M., Groenewegen H.J., Lopes D.A., Silva F.H. The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. Prog Neurobiol. 42:1994;719-761.
36. Pilla M., Perachon S., Sautel F., Garrido F., Mann A., Wermuth C.G., et al. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature. 400:1999;371-375.
37. Pulverenti L., Koob G.F. Dopamine agonists, partial agonists and psychostimulant addiction. Trends Pharmacol Sci. 15:1994;374-379.
38. Ridray S., Griffon N., Souil E., Mignon V., Carboni S., Diaz J., et al. Coexpression of dopamine D1 and D3 receptors in rat ventral striatum: opposite and synergistic functional interactions. Eur J Neurosci. 10:1998;1676-1686.
39. Segal D.M., Moraes C.T., Mash D.C. Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities. Mol Brain Res. 45:1997;335-339.
40. Self D.W., Nestler E.J. Relapse to drug-seeking: neural and molecular mechanisms. Drug Alcohol Dep. 51:1988;49-60.
41. Sokoloff P., Giros B., Martres M.P., Bouthenet M.L., Schwartz J.C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 347:1990;146-151.
42. Spealman R.D. Dopamine D3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther. 278:1996;1128-1137.
43. Spealman R.D., Bergman J., Madras B.K., Melia K.F. Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes. J Pharmacol Exp Ther. 258:1991;945-953.
44. Staley J.K., Mash D.C. Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci. 16:1996;6100-6106.
45. Stewart J. Conditioned and unconditioned drug effects in relapse to opiate and stimulant drug-administration. Prog Neuropsychopharmacol Biol Psychiatry. 7:1983;591-597.
46. Tella S.R. Differential blockade of chronic versus acute effects of intravenous cocaine by dopamine receptor antagonists. Pharmacol Biochem Behav. 48:1994;151-159.
47. Wilker A. Dynamics of drug dependence. Arch Gen Psychiatry. 28:1973;611-616.
48. Woolverton W.L., Cervo L., Johanson C.E. Effects of repeated methamphetamine administration on methamphetamine self-administration in rhesus monkeys. Pharmacol Biochem Behav. 21:1984;737-741.
49. Zahm D.S., Brog J.S. On the significance of subterritories in the 'accumbens' part of the rat ventral striatum. Neuroscience. 50:1992;751-767.